Private equity-backed One Medical launches IPO

Amy Baxter | | Health Exec | Digital Transformation

San Francisco-based One Medical, a membership primary care company, has launched its initial public offering with a starting share price of $14. The company expected to gain gross proceeds of $245 million.

One Medical signaled in early January it was filing for an IPO. The company is backed by several high-profile private equity groups, including The Carlyle Group, GV (formerly Google Ventures) and J.P. Morgan. Its rise to an IPO underscores the booming private equity interest in the healthcare space. While the company has been touted as innovative and representing the future of healthcare, the company has yet to turn a profit, reporting a net loss of $34.2 million for the first nine months of 2019.

One Medical is a primary care company that is based on a membership model. Members pay $199 annually for access to primary care physicians and same-day appointments at its 77 physical offices in nine major U.S. cities. Patients also have access to virtual care at any time. The company launched in 2007 and has nearly 400,000 members in its ranks.

The company is trading on the Nasdaq under the moniker ONEM. 1Life Healthcare is the administrative and managerial services company for affiliated One Medical physician owned professional corporations, and both entities do business under the One Medical name, according to a press release.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Machine learning vs. bodily pain: 5 points of promise and challenge
Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that
4 important AMA insights into physician thinking on, behavior with healthcare AI
Global consortium: The future of AI in healthcare is dynamic—and demanding
Healthcare systems are proceeding apace with GenAI—and learning as they go

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”